1. Introduction {#s0005}
===============

Limbic encephalitis (LE) is an autoimmune disease characterized by subacute short-term memory loss and psychiatric conspicuity. It often involves temporal lobe epilepsy ([@b0040], [@b0100], [@b0070]). To date, a variety of autoantibodies related to different LE subtypes have been identified. Antibodies against the intracellular antigen glutamic acid decarboxylase 65 (GAD) and against the extracellular antigen voltage-gated potassium channel complex (VGKC) rank among the most common autoantibodies associated with LE ([@b0080]). Within the VGKC-complex, two components that are targeted by different autoantibodies have been found ([@b0140], [@b0160], [@b0215], [@b0050]): Leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2). Even though different LE subtypes share clinical features, they differ in relevant aspects such as comorbidities and, most relevant, their response to immunotherapy ([@b0185]). As the presence of pathologic neuronal autoantibodies yet undiscovered may not be excluded by negative antibody testing, diagnostic weight is added on clinical examinations and magnetic resonance imaging (MRI) ([@b0075]). Recent research indicates that MRI features of LE depend on the type of autoantibody harbored by the patient. Mesiotemporal structures have been shown to be initially- and predominantly affected by LE; in particular amygdala and hippocampal swelling has been described ([@b0085], [@b0110], [@b0255], [@b0095]). Besides, there is growing evidence for serospecific structural alterations also in white matter regions caused by the disease. While a recent study investigating white matter features of LE by means of diffusion tensor imaging (DTI) found widespread alterations of diffusivity parameters in patients with GAD-autoantibody associated LE (GAD-LE), no white matter alterations in patients with VGKC-autoantibody associated LE have been observed ([@b0250]). However, the accuracy of conventional DTI-methods for reflecting the result of pathophysiological processes in white matter remains questionable. Conventional DTI relies on measures averaged across the volume of one voxel, despite the fact that roughly 90% of white matter voxels contain multiple fiber orientations ([@b0150]). To address this issue in the present study, we chose to apply fixel-based analysis, where metrics are derived from the specific estimated fiber orientation distribution for each white matter voxel ([@b0200]). Here, two metrics are combined for each distinct fiber population within a voxel: Fiber cross-section (FC) provides information on a macroscale, while fiber density (FD) assesses microstructural properties. By combining information on both scales, we hypothesized fixel-based analysis to draw a more detailed picture of white matter alterations to enhance future diagnostics. Studies applying fixel-based analysis to patients with hippocampal sclerosis (HS) found tract-specific atrophy on both hemispheres ([@b0235]). In this study, we aimed to compare GAD-LE, LGI1-associated LE (LGI1-LE), CASPR2-associated LE (CASPR2-LE), chronic temporal lobe epilepsy patients with HS and healthy controls to investigate the disturbed structure--function relationship, hoping to unmask structural underpinnings of clinical and neuropsychological alterations in LE patients.

2. Materials and methods {#s0010}
========================

2.1. Study groups {#s0015}
-----------------

This study comprised three experimental and two control groups: GAD-LE, LGI1-LE and CASPR2-LE formed three study groups. Patients with hippocampal sclerosis (HS) and healthy subjects constituted two control groups. First, we prospectively ascertained 19 patients with GAD-LE (mean age = 35.9 years, 11 females), 4 patients with LGI1-LE (mean age = 63.3, 2 females) and 5 patients with CASPR2-LE (mean age = 57.4, 0 females) who presented at the Department of Epileptology at the University Hospital Bonn between April 2008 and November 2016. All patients included in this study were diagnosed with autoimmune limbic encephalitis according to the widely acknowledged diagnostic criteria set forth by [@b0105]. Results of conventional DTI-analysis of a partly overlapping study group were previously published by [@b0250]. Moreover, autoantibodies against either GAD, LGI1 or CASPR2 were serologically proven in all patients included in this study (see below). Disease onset was defined as the onset of the first LE-associated symptoms. Second, we included 20 matched patients (mean age = 34.1, 11 females) with histologically confirmed HS and no suspicion of LE who presented for presurgical evaluation at our department between May 2008 and October 2013. This additional control group was included since we aimed to specifically detect autoimmune-mediated structural alterations caused by the respective autoantibodies and not those alterations that occur due to persistent temporal lobe epilepsy. HS subjects were individually matched to GAD-, LGI1- and CASPR2-LE with respect to the age at study, gender and the affected hemisphere. Subjects with dual pathologies were excluded from the study. Third, we composed three age- and gender-matched groups of healthy subjects with no history of neurological or psychiatric disorders from a pre-existing in-house database to be contrasted to GAD-LE, LGI1-LE and CASPR2-LE, respectively (GAD-LE healthy controls: mean age = 34.6 years, 11 females; LGI1-LE healthy controls: mean age = 57.0 years, 4 females; CASPR2-LE healthy controls: mean age = 57.2 years, 0 females). For the LGI1-LE and CASPR2-LE healthy control groups, two healthy subjects were matched to each patient to increase statistical power. Clinical data of all patients including memory performance (Verbal memory: VLMT; [@b0120], figural memory: DCS-R; [@b0125]) were retrieved from our in-house database. See [Table 1](#t0005){ref-type="table"} for groups characteristics (further details are provided in [Supplementary Tables S1--S4](#s0120){ref-type="sec"}). The study was approved by the Internal Review Board of the University Hospital Bonn and all participants provided written informed consent.Table 1Demographic- and clinical data of all patient- and control groups. All values are arithmetic group means (range). Verbal memory test: VLMT [@b0120], figural memory test: DCS-R [@b0125], memory parameters were standardized according to a conormalization sample of 488 healthy volunteers (mean = 100, standard deviation = 10), applying a correction for age. ^a^one subject is included in both groups, ^b^3 subjects are included in both groups, ^c^4 subjects are included in both groups, ^d^4 subjects are included in both groups, ^e^2 subjects are included in both groups, NA: not applicable, y: years.**LEcontrolsHSANOVAGroup**GADLGI1CASPR2(GAD)(LGI1)(CASPR2)(GAD)(LGI1)(CASPR2)*p***Number**194519^a^8^b^10^a,b^19^c,d^4^c,e^5^d,e^NA**Female (%)**11 (58)2 (50)0 (0)11 (58)4 (50)0 (0)11 (58)2 (50)0 (0)NA**Lateralization right (%)**5 (26)2 (50)1 (20)NANANA7 (37)2 (50)1 (20)NA**Age (y)**35.9 (20--61)63.3 (57--69)57.4 (40--72)34.6 (20--50)57.0 (23--67)57.2 (44--67)35.1 (18--59)52.6 (46--59)42.7 (26--50)\<0.001**Age at onset (y)**31.2 (16--56)61.4 (57--67)54.4 (39--69)NANANA15.7 (0--34)6.5 (0--14)9.3 (0--30)\<0.001**Disease duration (y)**4.6 (0--22)1.9 (0--5)3.0 (1--5)NANANA19.3 (5--47)46.0 (40--50)33.5 (15--50)\<0.001**Verbal memory**96.7 (71--108)83.6 (70--108)88.8 (78--92)NANANA86.1 (63--100)90.5 (80--99)84.5 (77--91)0.065**Figural memory**88.5 (65--108)77.5 (61--99)91.9 (81--107)NANANA84.1 (61--102)84.3 (75--87)80.8 (66--87)0.595**Seizure-free (%)**4 (21)3 (75)2 (40)NANANA1 (5)0 (0)1 (20)NA

2.2. Antibody testing {#s0020}
---------------------

From 2014 on, screening for onco-neuronal antibodies was performed using semiquantitative immunoblots (EUROLINE PNS 12, Euroimmun, DL 1111--1601-7 G) coated with recombinant antigen or antigen fragments (dilution: serum 1:100, cerebrospinal fluid: 1:1). Moreover, immunocytochemistry was performed using HEK293-cells (Human Embryonic Kidney 293) with expression of antigens on the cell surface (IIFT: Autoimmune-Enzephalitis-Mosaik1, Euroimmun, FA 1120--1005-1; GAD65-IIFT, Euroimmun, FA 1022--1005-50) for NMDAR-, CASPR, LGI1, GABAA-, GABAB-, AMPAR- and GAD65-autoantibodies (dilution: serum 1:10, cerebrospinal fluid: 1:1). Before 2014, detection of GAD antibodies in serum was performed by using an Anti- 125 I-GAD-radioimmunoprecipitation assay (normal values ≤1 U/ml; Weatherall Institute, Oxford, UK, or Euroimmun, Lübeck, Germany). VGKC-complex antibodies were detected by radioimmunoprecipitation assay (normal values \< 100 pM; Weatherall Institute or Euroimmun). Antibodies against LGI1 and CASPR2 were examined by indirect immunofluorescence using formalin fixed HEK293 cells containing membrane bound LGI1 or CASPR2 (normal values \<1 : 10; all tests performed by Euroimmun).

2.3. Neuropsychological assessment {#s0025}
----------------------------------

Neuropsychological testing was performed within 100 days of the scan. Abilities in figural learning and the overall memory performance were assessed using the revised *Diagnosticum fuer Cerebralschaedigung* (DCR-R; [@b0125]). Abilities in verbal learning and the overall memory performance were assessed using the verbal learning and memory test (VLMT; [@b0120]). Memory parameters were standardized according to a conormalization sample of 488 healthy volunteers (mean = 100, standard deviation = 10), applying a correction for age.

2.4. MRI examinations {#s0030}
---------------------

Diffusion Tensor Imaging (DTI) for all subjects was performed at the Life & Brain Center in Bonn using a 3 Tesla MRI-Scanner (Magnetom Trio, Siemens Healthineers, Erlangen, Germany). Diffusion-weighted data were acquired using single shot spin-echo echo-planar imaging. Due to a scanner update in early 2014, two different acquisition protocols were used. Parameters before the update were TR = 12 s, TE = 100 ms using an eight channel headcoil, parameters after the update were TR = 9 s, TE = 87 ms using a 32 channel headcoil. Both protocols acquired 72 axial slices, matrix 128 × 128, voxel size 1.72 mm × 1.72 mm × 1.7 mm and in both protocols, diffusion weighting was isotropically distributed along 60 directions at b = 1000 s · mm^−2^. Six images with *b* = 0 were acquired initially and following each series of ten diffusion-weighted images. Healthy control groups were matched with regard to sequences before and after the scanner update.

2.5. Reorientation of images {#s0035}
----------------------------

Cortical reconstruction and volumetric segmentation of T1-weighted images was performed using FreeSurfer (version 6.0; [@b0090]; <http://surfer.nmr.mgh.harvard.edu>). As it remains unclear whether LE is a predominantly unihemispheric process ([@b0175]), we defined either the right, the left or both hemispheres as *affected* hemispheres using a two-step classification scheme according to [@b0085]). Interictal EEG data acquired during the same hospital stay as the MRI examination were used as primary criterion: The hemispheres presenting pathological interictal EEG potentials were classified as the *affected* hemisphere. If EEG data were not available, we used the right/left amygdala volumetric ratio, calculated as 2(*V*~R~ − *V*~L~)/(*V*~R~ + *V*~L~), as a secondary criterion: If the amygdala volumetric ratio was in the upper quartile as compared to controls, the right hemisphere was defined as *affected* hemisphere. If the amygdala volumetric ratio was in the lower quartile as compared to controls, the left hemisphere was defined as *affected* hemisphere. In between, we regarded both hemispheres as *affected*. For whole-brain fixel-based analysis and subsequent group-wise comparisons, we flipped all LE and HS patients with affected right hemispheres along the left--right axis. For ROI-wise correlation analysis with neuropsychological tests, we used the native (unflipped) image orientation.

2.6. Fixel-based preprocessing {#s0040}
------------------------------

Fixel-based analysis was performed using the MRtrix3 toolbox (The Florey Institute, Melbourne, Australia; <http://mrtrix.readthedocs.io>). The principle behind this approach is to use constrained spherical deconvolution and probabilistic tractography to compute metrics on anatomically plausible fiber populations. Preprocessing of diffusion-weighted images included denoising ([@b0240]), motion and eddy current distortion correction ([@b0015], [@b0010]) using the FMRIB software library (FSL, Version 5.0; [@b0145]; <http://www.fmrib.ox.ac.uk/fsl>) and N4 bias field correction ([@b0230]). Next, we performed group intensity normalization to the median white matter b = 0 signal and upsampled images to (1.3 mm)^3^ voxel size in order to improve downstream spatial normalization statistics. We computed a group average single-shell white matter response function ([@b0225]), performed constrained spherical deconvolution ([@b0155]) in order to estimate the fiber orientation distribution function (FOD) for all subjects and generated a study-specific group FOD template from a representative subgroup comprising 45 images. FOD template and subject FOD images were segmented to discrete fixels ([@b0205]). Subject FOD and all subsequent images were then registered to the group template. Subsequently, we calculated values for FD ([@b0195]), and FC ([@b0200]) for all subject fixel images. Furthermore, we computed fiber density and cross-section as FDC = FD · FC and ln(FC) images. ln(FC) images were computed to ensure data were normally distributed and centered around zero for downstream statistical analysis. We performed whole-brain probabilistic tractography on the FOD template selecting 20 · 10^6^ streamlines with a length between 10 and 250 mm and a maximum angle of 22.5°. To correct for tractography biases, we performed spherical deconvolution informed filtering ([@b0205]) and reduced the number of streamlines to 2 · 10^6^. See [Fig. 1](#f0005){ref-type="fig"} for an overview on the processing pipeline. We tested for differences in FD and FC fixel values between both MRI acquisition setups used and did not find any differences within the healthy control group.Fig. 1Overview over the processing pipeline. Fixel-based analysis was performed using the MRtrix3 toolbox. It was conducted as proposed by [@b0200]). FC: fiber cross-section, FD: fiber density, FOD: Fiber orientation distribution.

2.7. Statistical analysis {#s0045}
-------------------------

Analysis was conducted following a two-tier strategy: First, fixel-wise analysis was conducted and, second, mean fixel values of resulting clusters were used for ROI-wise group comparisons or correlation analysis with neuropsychological assessment metrics. Cross-sectional statistical analysis of fixel-based metrics was performed using connectivity-based fixel enhancement ([@b0190], parameters: *C* = 0.75, *E* = 3.5, *H* = 4) and fixel-wise non-parametric permutation testing (5000 permutations) with the MRtrix3 toolbox. By smoothing and enhancing fixels along the template streamlines, this method puts additional weight on local fixel-fixel connectivity and determines significant fixels that are structurally connected. Second, fixels from resulting clusters were extracted, averaged, and subjected to ROI-wise comparisons and correlation analysis: For comparison of means of independent numerical data across more than two groups, we used one-way analysis of variance and post-hoc Tukey-Kramer test for pair-wise comparisons including a correction for multiple comparisons. Correlation analysis was carried out using Pearson correlation and Steiger's *Z*-test. The Holm-Bonferroni procedure was applied to adjust *p*-values for multiple testing ([@b0135]). ROI-wise statistical analyses were performed using Stata 14 (Stata Statistical Software: Release 14, StataCorp LP, College Station, TX, USA). In this study, we regard a probability value *p* \< 0.05 as statistically significant.

3. Results {#s0050}
==========

3.1. Clinical group differences {#s0055}
-------------------------------

All study groups were compared using one-way analysis of variance with Tukey-Kramer post-hoc pairwise testing. Between LE groups, we found a significantly lower age at study and age at disease onset in GAD-LE as compared to LGI1-LE (age at study: Tukey-Kramer *p* \< 0.001, age at disease onset: Tukey-Kramer *p* \< 0.001) and CASPR2-LE (age at study: Tukey-Kramer *p* \< 0.001, age at disease onset: Tukey-Kramer *p* \< 0.001). Disease duration did not differ significantly neither between GAD-LE and LGI-LE (Tukey-Kramer *p* = 0.994) nor between GAD-LE and CASPR2-LE (Tukey-Kramer *p* = 0.999). Between LE groups and the matched HS groups, in all LE groups the age at disease onset was significantly higher and disease duration was significantly shorter as compared to the matched HS group (all Tukey-Kramer *p* \< 0.001). LE groups and HS control groups did not differ significantly in verbal memory performance (*F*(5,50) = 2.23, *p* = 0.065) or figural memory performance (*F*(5,50) = 0.74, *p* = 0.595).

3.2. Fixel values group differences between GAD-LE and control groups {#s0060}
---------------------------------------------------------------------

Fixel-wise group comparisons revealed three clusters with significantly lower FDC in GAD-LE versus controls: First and second, we found a significant reduction of FDC in fibers associated to the superior longitudinal fascicle (SLF) on both the *affected* (1) and *unaffected* (2) hemispheres with an average reduction of −5.4% in the *affected* (*t*~max~ = 4.57, *p*~min~ = 0.036, FWE-corrected) and −5.0% in the *unaffected* hemisphere (*t*~max~ = 5.25, *p*~min~ = 0.002, FWE-corrected). Third, we found a significant reduction of FDC in crossing fibers (3) located in the isthmus of the corpus callosum (*t*~max~ = 4.88, *p*~min~ = 0.012, FWE-corrected; see [Fig. 2](#f0010){ref-type="fig"}A). FDC reduction was driven by a reduction of both FD and FC (see [Supplementary Table S5](#s0120){ref-type="sec"}). In a second step, we projected the (more extensive) SLF-cluster in the *unaffected* hemisphere cluster to the contralateral/*affected* hemisphere, extracted and averaged fixels from both clusters and computed whole-brain-corrected FDC fixel values within the SLF on both hemispheres. Consecutive ROI-wise analysis of covariance adjusting for age and post-hoc pairwise testing confirmed significantly lower bihemispheric FDC values in GAD-LE patients (*F*(9,152) = 6.57, η^2^ = 0.28, *p* \< 0.001; see [Fig. 2](#f0010){ref-type="fig"}B and [Supplementary Table S6](#s0120){ref-type="sec"}) as compared to healthy controls (Tukey-Kramer, *affected* hemisphere: *p* \< 0.001, *unaffected* hemisphere: *p* = 0.029). ROI-wise analysis of control patients with HS showed unilaterally lower FDC values only in the *affected* hemisphere as compared to healthy controls (Tukey-Kramer, *p* \< 0.001). ROI-wise analysis of CASPR2-LE patients also revealed unilaterally lower FDC values only in the *affected* hemisphere as compared to healthy controls (Tukey-Kramer, *p* = 0.003), the *unaffected* hemisphere in LGI1-LE (Tukey-Kramer, *p* = 0.015) and the *unaffected* hemisphere in HS (Tukey-Kramer, *p* = 0.042). In a second analysis of covariance adjusting all LE and HS groups for age and seizure freedom (*F*(9,86) = 2.71, η^2^ = 0.22, *p* = 0.008; see [Supplementary Table S7](#s0120){ref-type="sec"}), lower FDC values in the *affected* hemisphere in CASPR2-LE than in the *unaffected* hemisphere in LGI1-LE remained significant (Tukey-Kramer, *p* = 0.013), whereas the *affected* hemisphere in CASPR2-LE did no longer show significantly lower FDC values than the *unaffected* hemisphere in HS (Tukey-Kramer, *p* = 0.211). After adjusting for seizure freedom, we found significantly lower FDC values in the *affected* hemisphere in HS patients than in the *unaffected* hemisphere in LGI1-LE (Tukey-Kramer, *p* = 0.035).Fig. 2Summary of fixel-based analysis results. (A) Display of streamlines associated to fixels with significant (*p* \< 0.05, FWE-corrected) reduction of FDC in GAD-LE versus controls. (B) Whole-brain corrected mean FDC values in the extracted superior-longitudinal-fascicle-ROI for all groups are shown. ^a^Results did not remain significant after adjusting for seizure freedom. ^b^Results was only significant after adjusting for seizure freedom. HC: healthy controls; HS: control patients with hippocampal sclerosis; unaff.: unaffeceted; \*: *p* \< 0.05, \*\*: *p* \< 0.01, \*\*\*: *p* \< 0.001.

3.3. Fixel values group differences between LGI1-LE and control groups {#s0065}
----------------------------------------------------------------------

Fixel-wise group comparison did not reveal any cluster with significantly different FD, ln(FC) or FDC neither between LGI1-LE and healthy controls (*p*~min~ \> 0.05, FWE-corrected) nor between LGI1-LE and HS (*p*~min~ \> 0.05, FWE-corrected).

3.4. Fixel values group differences between CASPR2-LE and control groups {#s0070}
------------------------------------------------------------------------

Fixel-wise group comparison did not reveal any cluster with significantly different FD, ln(FC) or FDC between CASPR2-LE and healthy controls (*p*~min~ \> 0.05, FWE-corrected). While FD did not differ significantly between CASPR2-LE and HS, we found a small cluster of significantly higher ln(FC) and FDC in the cerebellar peduncle on CASPR2-LE versus HS (*t*~max~ = 10.16, *p*~min~ = 0.01, FWE-corrected).

3.5. Correlation between ROI-wise fixel values and neuropsychological test results {#s0075}
----------------------------------------------------------------------------------

Moreover, we performed correlation analysis in an explorative design between fixel values extracted from the SLF-ROI found in cross-sectional analysis and neuropsychological scores within the GAD-LE group (see [Fig. 3](#f0015){ref-type="fig"} and [Supplementary Table S8](#s0120){ref-type="sec"}). For this analysis, as memory is known to be lateralized, we used a "native" left/right orientation in addition to the orientation according to the hemisphere affected by the disease. We found a significant correlation (*R* = 0.64, Holm-Bonferroni corrected *p* \< 0.048) between the left/right ratio of whole brain corrected FC values in the SLF and the assessed verbal memory score. We did not find any correlation between hippocampal volumes and figural or verbal memory performance (uncorrected *p* \> 0.05).Fig. 3Results of explorative ROI-wise correlation analysis with neuropsychological performance in the GAD-LE group. Correlation between Left/Right ratio of fiber cross-section values in the extracted SLF-ROI and verbal memory performance (*R* = 0.64, Holm-Bonferroni corrected *p* = 0.048; FC: fiber cross-section; SLF: superior longitudinal fascicle; L: left; R: right.

3.6. Regression of ROI-wise fixel values by clinical features {#s0080}
-------------------------------------------------------------

We performed regression analysis in order to link our finding of lower FDC in the SLF-ROI with clinical features. Within the HS group, FDC values in the SLF in the affected hemisphere were predicted by a linear regression model (*F*(2,17) = 5.23, *p* = 0.017, *R*^2^ = 0.38) including disease duration and age at onset as covariates (see [Fig. 4](#f0020){ref-type="fig"}). While we found a significant effect of the disease duration (*t* = -3.22, *p* = 0.004), the contribution of age at onset was not significant (*t* = -1.55, *p* = 0.140). Within the GAD-LE group, the same model did not significantly predict FDC values in the SLF neither of the affected hemisphere (*F*(2,16) = 0.48, *p* = 0.628) nor pooled across both hemispheres (*F*(2,16) = 0.82, *p* = 0.451).Fig. 4Results of regression analysis of FDC in the affected superior longitudinal fascicle. Within the hippocampal sclerosis group (right and top), FDC values were predicted (*F*(2,17) = 5.23, *p* = 0.017, *R*^2^ = 0.38) by disease duration (*t* = −3.22, *p* = 0.004) and age at onset(*t* = −1.55, *p* = 0.140) , while only the contribution of disease duration was significant (top). Within the GAD-LE group, the same model failed (*F*(2,16) = 0.48, *p* = 0.628) to predict FDC values in the affected superior longitudinal fascicle (left). FDC: fiber density and cross-section; SLF: superior longitudinal fascicle; yrs: years.

4. Discussion {#s0085}
=============

Using the novel approach of fixel-based analysis, our study reveals distinct fiber tract alteration patterns in patients with LE that can be related to the associated antibody. GAD-LE showed bilaterally lower fiber density and cross-section (FDC) in the SLF as compared to healthy controls, while this reduction was present only in the *affected* hemisphere in CASPR2-LE and was not present at all in LGI1-LE. Correlation analysis finally draws a link between the altered SLF and memory performance further suggesting the functional relevance of our findings.

4.1. Clinical group differences {#s0090}
-------------------------------

Analyses of clinical features confirm serogroup characteristics previously described in several studies ([@b0170], [@b0045], [@b0105], [@b0070]): GAD-LE were significantly younger at the onset of the disease than LGI1-LE and CASPR2-LE patients. Also, there were more female patients in the group of GAD-LE ([@b0105]). The disease onset of all LE-groups was much later than in the HS patient control groups, where first symptoms appeared in childhood. As expected, all LE and HS patients equally showed impaired figural and verbal memory performance.

4.2. Fixel-based analysis reflects serostatus {#s0095}
---------------------------------------------

In GAD-LE, widespread reductions of fractional anisotropy have been observed by means of conventional DTI ([@b0250]). Using fixel-based analysis, this finding could be narrowed down to two fiber tracts affected by significant FDC reduction: Crossing fibers in the isthmus of the corpus callosum and in the SLF in both hemispheres. Reduction of diffusivity parameters in the corpus callosum have been repeatedly observed and discussed ([@b0260], [@b0055]). It is subject to an ongoing debate whether they are a consequence of seizures, a part of the underlying pathology, or a contribution of genetics ([@b0235]). Structural affection of the *affected* SLF is also known to occur in temporal lobe epilepsy: Reduced FDC of the SLF ([@b0200], [@b0205], [@b0235]) and FA reduction ([@b0180]) could be shown by previous studies and is now confirmed by findings in our HS patient control group. The bilateral affection of the SLF found in GAD-LE, however, is novel and may be interpreted as bilateral axonal damage caused by persisting seizures involving a network not limited to the *affected* hemisphere ([@b0005], [@b0180], [@b0060]) or as part of the pathologic process in autoimmune encephalitis. In LGI1-LE, a unilateral disease onset is discussed ([@b0175], [@b0085]). Our results, in contrast, failed to reveal any asymmetrical white matter alteration patterns in this group. This might be due to the fact that not all LGI1-LE patients are identified in the early disease stage or due to the very small sample size. Notably, despite small sample sizes, CASPR2-LE showed reduced FDC in the SLF limited to the *affected* hemisphere. Considering the older age at disease onset of LE patients in comparison to HS control patients, it remains open which amount of FDC reduction in the SLF is purely grounded in the autoimmune pathology of LE or simply a consequence of persisting seizures, as it is the case in HS where FDC reduction in the SLF is significantly associated with disease duration. Based on our data, such a link cannot be drawn for LE, especially GAD-LE. Notably, different age at disease onset has been shown to influence the vulnerability of the brain to seizures and the potential for neuroplasticity ([@b0030], [@b0025]), which is why the direct comparison between LE subgroups and HS has to be made with caution.

4.3. Functional relevance of structural alterations {#s0100}
---------------------------------------------------

We discuss our finding of lower FDC in GAD-LE versus controls located within the SLF in the light of verbal memory performance, a cognitive domain most commonly impaired in temporal lobe epilepsy ([@b0115], [@b0130]). It is widely recognized that both affected SLF subdivisions, the SLF II and SLFIII, are key components of the dorsal language processing stream and involved in mediating between language functions and working memory ([@b0020], [@b0035], [@b0165], [@b0210]). Our data, showing a positive correlation between the left-greater-than-right asymmetry of FC values within the SLF and verbal memory, is in line with previous studies applying DTI based measures ([@b0245], [@b0065], [@b0220]). This underlines the concept that integrity of superordinated organizational properties of the language processing system rather than isolated damage to one component predicts verbal memory performance ([@b0065]).

4.4. Limitations and outlook {#s0105}
----------------------------

There are three major limitations to the current study. The first limitation lies in the study design: Transversal study designs like the current one are challenged by therapeutic interventions. GAD-LE has been described to be less responsive to immunotherapy as compared to LGI1-LE and CASPR2-LE ([@b0105]). It is, therefore, difficult to discriminate whether differences observed between groups reflect the response to differing treatments or the natural course of the disease. Second, small sample sizes and heterogeneity especially of the LGI1-LE and CASPR2-LE groups limit the ability of the present study to reveal distinct serospecific properties. Notably, because of this limitation, this study did not reveal any significant group differences when comparing LE subgroups against each other. Third, the interpretation of fixel-based measures, mostly in analogy to DTI measures, remains speculative. Yet, in order to increase the value of those metrics as meaningful imaging biomarkers offering pathomechanistic insight, a more detailed understanding of the histopathological underpinnings is essential. Therefore, future studies investigating histolopathological correlates of imaging measures are needed.

5. Conclusion {#s0110}
=============

Imaging research in LE has recently been focused on mesiotemporal gray matter structures. However, in DTI studies it became evident that white matter structures also undergo pathological changes. In the current study, fixel-based analysis has proven to be a useful tool for the detection of distinct microstructural white matter alterations and could show their functional relevance. It is our hope that the current study, as well as future studies, will help in unveiling the pathomechanism of LE, thereby, strengthening the role of MRI in the diagnosis of LE patients.
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